Daiichinkyo CoDSNKY -1.98%71 Shareholder Yield % is 2.85% as of Mar. 2026, which is 40% above its 10-year median of 2.03. GuruFocus rates DSNKY with a GF Score™ of 71/100 and a GF Value™ of $37.73 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 973 Drug Manufacturers companies, Daiichinkyo Co ranks better than 70.71% on this metric.
Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. It is a measure of shareholder return.
As of today, Daiichinkyo Co's Shareholder Yield % was 2.85%.
Daiichinkyo Co (OTCPK:DSNKY) Shareholder Yield % Explanation
Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. The term was coined by William W. Priest of Epoch Investment Partners in a paper in 2005 entitled The Case for Shareholder Yield as a Dominant Driver of Future Equity Returns. William Priest indicated that "shareholder yield is a term that we came up with to reflect the various ways dividends can be paid to owners of a business in a publicly-traded company."
Dividend Yield % shows how much a company pays out in dividends each year relative to its stock price, which is most obvious form of shareholder return.
Buyback Yield % is the net repurchase of shares outstanding over the market capital of the company. Shares repurchases also increase shareholder value by returning the money back to shareholders.
Net Debt Paydown Yield % is the change in average of four quarters of company's total debt over a company's market cap. Assuming the total value of a company remains that same, shareholder value is increased as debt is reduced.
Daiichinkyo Co Shareholder Yield % Related Terms
Daiichinkyo Co Shareholder Yield % Historical Data
* Premium members only.
The historical data trend for Daiichinkyo Co's Shareholder Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DSNKY vs LLY, JNJ, ABBV: Shareholder Yield % Comparison
For the Drug Manufacturers - General subindustry, Daiichinkyo Co's Shareholder Yield %, along with its competitors' market caps and Shareholder Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Daiichinkyo Co Shareholder Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Daiichinkyo Co's Shareholder Yield % distribution charts can be found below:
* The bar in red indicates where Daiichinkyo Co's Shareholder Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* All the data are calculated by TTM values. Note that if a companies is traded in several exchanges, then we calculate the company level data for Shareholder Yield % using the primary share class stock data. The calculation result in definition page is for demonstration purpose only, and it's showing the share class level data. Therefore, the numbers in the calculation may differ from elsewhere if the stock is not a primary share.
Daiichinkyo Co (DSNKY) has a Shareholder Yield % of 2.85% as of Mar. 2026. Shareholder Yield is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. View historical data on Daiichinkyo Co and its competitors. This is 40% above median its historical median of 2.03. Over the past decade, Daiichinkyo Co's Shareholder Yield % has ranged from 0.25 to 11.79. According to the industry distribution chart, Daiichinkyo Co ranks #285 out of 973 companies in the Drug Manufacturers industry, placing it in the top 29.3%.
Is Daiichinkyo Co's Shareholder Yield % too high?
Daiichinkyo Co's current Shareholder Yield % of 2.85% is 40% above median its 10-year median of 2.03. Over the past 10 years, this metric has ranged from a low of 0.25 to a high of 11.79. The Drug Manufacturers industry median Shareholder Yield % is 0.30. Daiichinkyo Co's value of 2.85% is 850% above this industry median. Based on the distribution chart, Daiichinkyo Co ranks #285 out of 973 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Daiichinkyo Co has a GF Score™ of 71/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Daiichinkyo Co's Shareholder Yield % compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Daiichinkyo Co ranks #285 out of 973 companies for Shareholder Yield %. This puts Daiichinkyo Co in the upper half of its industry. The industry median Shareholder Yield % is 0.30. Daiichinkyo Co's value of 2.85% is 850% above this benchmark. Historically, Daiichinkyo Co's own Shareholder Yield % has ranged from 0.25 to 11.79 over the past decade. While the company's 10-year median is 2.03 vs. the industry median of 0.30, Daiichinkyo Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shareholder Yield % for a Drug Manufacturers company?
The median Shareholder Yield % among Drug Manufacturers companies is 0.30, based on 973 companies in the industry. Companies in the top quartile (top 25%) have a Shareholder Yield % significantly above this median, while those in the bottom quartile fall well below. However, Shareholder Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Daiichinkyo Co's current Shareholder Yield % of 2.85% is 850% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shareholder Yield % mean?
A high Shareholder Yield % can signal that a stock is expensive relative to its fundamentals. Shareholder Yield is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. View historical data on Daiichinkyo Co and its competitors. For the Drug Manufacturers industry, the median Shareholder Yield % is 0.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Daiichinkyo Co's current Shareholder Yield % is 2.85%, which is 40% above median its own 10-year median of 2.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Daiichinkyo Co stock overvalued right now?
Based on GuruFocus' analysis, Daiichinkyo Co (DSNKY) is currently considered Significantly Undervalued. The stock's GF Value™ is $37.73, compared to a current price of $16.82 — trading 55.4% below its estimated fair value. The current Shareholder Yield % is 2.85%, which is 40% above median its 10-year median of 2.03 and 850% above the Drug Manufacturers industry median of 0.30. Daiichinkyo Co's overall GF Score™ is 71/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shareholder Yield % calculated?
Shareholder Yield % is calculated from a company's financial statements. For Daiichinkyo Co (DSNKY), the current Shareholder Yield % is 2.85% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Daiichinkyo Co (DSNKY) Overvalued in 2026?
Based on GuruFocus' analysis, Daiichinkyo Co stock appears to be undervalued.
The current stock price of $16.82 is trading 55.4% below its estimated GF Value™ of $37.73.
GuruFocus considers Daiichinkyo Co to be Significantly Undervalued.
Key valuation signals for DSNKY:
Shareholder Yield %: 2.85% (40% above median its 10-year median of 2.03)
GF Value™: $37.73 vs. price of $16.82 (55.4% below fair value)
Industry Position: 850% above the Drug Manufacturers median (#285 of 973)
No single metric tells the full story. See the DSNKY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Daiichi Sankyo was established by the merger of Daiichi Pharmaceuticals and Sankyo in 2005. As of 2024, approximately one quarter of revenue comes from its Japan businesses, which will shrink in the future as the company expands its global footprint. Its primary growth driver is its leading platform of antibody drug conjugates, or ADCs. Its lead ADCs are Enhertu (HER2), Datroway (TROP2), I-DXd (B7-H3), HER3-DXd (HER3), and R-DXd (CDH6). Enhertu was first approved in the US in December 2019, and Datroway was first approved in January 2025.
71GF Score
Get the complete analysis for DSNKY
Shareholder Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DSNKY has been successfully added to your 
